Time
Days to earnings1 · imminent
Next print2026-10-13
WindowBMO
Fiscal2026-09-30
NYSE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
JNJ
Johnson & Johnson primary
264.03
Full stocks workspace →+2.54+1.0%
Street
Consensus EPS2.513
Consensus revenue25.4B
EPS high / low2.66 / 2.31 · 13.9% · n=11
Rev / avg0 / — · 2.482 / 2.425
Options
IV front32.2%
Implied move1.7%
Put/call full0.80
Put/call front0.91
Short interest
Short shares22.1M / 21.2M · +4.16%
Days to cover3.27
Avg vol · float6.8M · 2.4B
Short % float0.92%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 1 | 2026-10-13 | 264.03 | 2.513 | 32.2% | 1.7% | +4.4% | -2.9% | -0.9% | -1.5% | 2.66 / 2.31 | 13.9% | 11 | 0.80 | 0 | |
| 2026-10-09 | 2 | 2026-10-13 | 261.49 | 2.482 | 32.7% | 3.4% | +2.1% | -3.6% | -1.5% | -1.6% | 2.66 / 2.31 | 14.1% | 8 | 0.80 | 0 | |
| 2026-10-08 | 3 | 2026-10-13 | 256.51 | 2.482 | 31.7% | 3.7% | -0.8% | -5.2% | -3.7% | -5.0% | 2.66 / 2.31 | 14.1% | 8 | 0.80 | 0 | |
| 2026-10-07 | 4 | 2026-10-13 | 258.34 | 2.482 | 29.3% | 3.8% | -2.4% | -4.0% | -3.3% | -5.4% | 2.66 / 2.31 | 14.1% | 8 | 0.80 | 0 | |
| 2026-10-06 | 5 | 2026-10-13 | 254.80 | 2.482 | 30.3% | 4.2% | -4.8% | -5.3% | -5.3% | -6.7% | 2.66 / 2.31 | 14.1% | 8 | 0.80 | 0 | |
| 2026-10-05 | 6 | 2026-10-13 | 252.92 | 2.482 | 26.9% | 4.0% | -7.0% | -6.1% | -8.1% | -6.4% | 2.66 / 2.31 | 14.1% | 8 | 0.81 | 0 | |
| 2026-10-02 | 7 | 2026-10-13 | 256.10 | 2.453 | 29.3% | 5.1% | -5.6% | -5.1% | -8.0% | -4.2% | 2.66 / 2.31 | 14.3% | 6 | 0.82 | 0 | |
| 2026-10-01 | 8 | 2026-10-13 | 258.80 | 2.453 | 28.3% | 5.1% | -4.4% | -4.2% | -6.0% | -5.3% | 2.66 / 2.31 | 14.3% | 6 | 0.82 | 0 | |
| 2026-09-30 | 9 | 2026-10-13 | 264.79 | 2.453 | 28.8% | 5.4% | -1.6% | -0.9% | -2.4% | -2.3% | 2.66 / 2.31 | 14.3% | 6 | 0.81 | 0 | |
| 2026-09-29 | 10 | 2026-10-13 | 267.59 | 2.453 | 28.3% | 5.5% | -0.6% | +0.1% | +0.7% | +2.0% | 2.66 / 2.31 | 14.3% | 6 | 0.80 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| ABBV primary | AbbVie Inc | 0.49 | 2026Q2 · 2026-07-31 | +0.3% | -1.9% | 250.94 | 14 · 2026-10-12 |
| MRK primary | Merck & Company Inc | 0.47 | 2026Q2 · 2026-08-04 | +50.0% | +0.5% | 128.00 | 13 · 2026-10-12 |
| LLY primary | Eli Lilly and Company | 0.42 | 2026Q2 · 2026-08-05 | +39.4% | +5.2% | 1,169.86 | 13 · 2026-10-12 |
| ABT primary | Abbott Laboratories | 0.30 | 2026Q2 · 2026-07-16 | +2.3% | +6.7% | 98.83 | 7 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-07-15 | BMO | 2.90 | +2.1% | Beat | -1.5% | -1.2% | 1.45× | +7.5% | Review |
| 2026Q1 | 2026-04-14 | BMO | 2.70 | +0.7% | Beat | -1.2% | +2.2% | 1.50× | -5.1% | Review |
| 2025Q4 | 2026-01-21 | BMO | 2.46 | 0.0% | — | -3.3% | +3.3% | 1.54× | +7.6% | Review |
| 2025Q3 | 2025-10-14 | BMO | 2.80 | +1.4% | Beat | +1.1% | -1.1% | 1.58× | -2.1% | Review |
| 2025Q2 | 2025-07-16 | BMO | 2.77 | +3.4% | Beat | +3.3% | +2.8% | 3.14× | +1.5% | Review |
| 2025Q1 | 2025-04-15 | BMO | 2.77 | +7.4% | Beat | +0.9% | -1.3% | 0.74× | +1.8% | Review |
| 2024Q4 | 2025-01-22 | BMO | 2.04 | +1.5% | Beat | -2.8% | +0.9% | 1.80× | +6.5% | Review |
| 2024Q3 | 2024-10-15 | BMO | 2.42 | +9.5% | Beat | -1.0% | +2.6% | 2.10× | -2.4% | Review |
| 2024Q2 | 2024-07-17 | BMO | 2.82 | +4.4% | Beat | +0.4% | +3.3% | 2.48× | +0.8% | Review |
| 2024Q1 | 2024-04-16 | BMO | 2.71 | +2.3% | Beat | -1.7% | -0.4% | 1.82× | +0.1% | Review |